Kairos Pharma, Ltd.
KAPA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,603 | -$1,812 | -$1,050 | -$2,145 |
| Dep. & Amort. | $160 | $160 | $160 | $98 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $218 | $913 | $0 | $300 |
| Change in WC | -$1,984 | $764 | $129 | $1,191 |
| Other Non-Cash | $254 | $56 | $408 | $144 |
| Operating Cash Flow | -$3,955 | $81 | -$353 | -$412 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$109 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$109 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $895 | $330 |
| Stock Issued | $5,524 | -$425 | -$57 | $250 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$390 | $0 | -$121 | $0 |
| Financing Cash Flow | $5,134 | -$425 | $717 | $580 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,179 | -$344 | $364 | $59 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93 | $437 | $73 | $14 |
| End Cash | $1,272 | $93 | $437 | $73 |
| Free Cash Flow | -$3,955 | $81 | -$353 | -$412 |